Acumen Pharmaceuticals Inc (ABOS)
3.36
-0.20
(-5.62%)
USD |
NASDAQ |
May 10, 16:00
3.36
0.00 (0.00%)
After-Hours: 18:37
Acumen Pharmaceuticals Shareholders Equity (Quarterly): 266.97M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 266.97M |
| September 30, 2023 | 280.27M |
| June 30, 2023 | 168.87M |
| March 31, 2023 | 179.08M |
| December 31, 2022 | 188.78M |
| September 30, 2022 | 196.65M |
| June 30, 2022 | 206.52M |
| Date | Value |
|---|---|
| March 31, 2022 | 216.09M |
| December 31, 2021 | 225.18M |
| September 30, 2021 | 233.36M |
| June 30, 2021 | -106.08M |
| March 31, 2021 | -45.46M |
| December 31, 2020 | -18.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-106.08M
Minimum
Jun 2021
280.27M
Maximum
Sep 2023
153.20M
Average
196.65M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Accuray Inc | 41.08M |
| Kezar Life Sciences Inc | 187.57M |
| Akoya Biosciences Inc | 53.77M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 310.12M |
| Total Liabilities (Quarterly) | 43.15M |